🇮🇷 Iran Proxy | https://www.wikipedia.org/wiki/NOTCH3
Jump to content

NOTCH3

From Wikipedia, the free encyclopedia

NOTCH3
Available structures
PDBOrtholog search: PDBe RCSB
Identifiers
AliasesNOTCH3, CADASIL, CASIL, IMF2, LMNS, CADASIL1, notch 3, notch receptor 3
External IDsOMIM: 600276; MGI: 99460; HomoloGene: 376; GeneCards: NOTCH3; OMA:NOTCH3 - orthologs
Orthologs
SpeciesHumanMouse
Entrez
Ensembl
UniProt
RefSeq (mRNA)

NM_000435

NM_008716

RefSeq (protein)

NP_000426

NP_032742

Location (UCSC)Chr 19: 15.16 – 15.2 MbChr 17: 32.34 – 32.39 Mb
PubMed search[3][4]
Wikidata
View/Edit HumanView/Edit Mouse

Neurogenic locus notch homolog protein 3 (Notch 3) is a protein that in humans is encoded by the NOTCH3 gene.[5][6]

Function

[edit]

This gene encodes the third discovered human homologue of the Drosophila melanogaster type I membrane protein notch. In Drosophila, notch interaction with its cell-bound ligands (delta, serrate) establishes an intercellular signalling pathway that plays a key role in neural development. Homologues of the notch-ligands have also been identified in human, but precise interactions between these ligands and the human notch homologues remains to be determined.

Pathology

[edit]
Micrograph showing CADASIL with a Notch 3 immunostain

Mutations in NOTCH3 have been identified as the underlying cause of cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL).[6] Mutations in NOTCH3 have also been identified in families with Alzheimer's disease.[7] Adult Notch3 knock-out mice show incomplete neuronal maturation in the spinal cord dorsal horn, resulting in permanently increased nociceptive sensitivity.[8] Mutations in NOTCH3 are associated to lateral meningocele syndrome.[9]

Pharmaceutical target

[edit]

Notch3 is being investigated as a target for anti-cancer drugs, as it is overexpressed in several types of cancers.[10] Early clinical trials of Pfizer's PF-06650808, an anti-Notch3 antibody linked to a cytotoxic drug, showed efficacy against solid tumors.[11]

Mammalian evolution

[edit]

A recent study analyzed the NOTCH3 gene across 113 mammalian species to understand its evolution and links to human disease. The researchers discovered unusual natural variations, including eight cysteine changes in jaguar, a rare human-specific isoform shared with a few other mammals, and a unique regulatory deletion in Brandt’s bat. In humans, mutations in NOTCH3 can cause CADASIL, a hereditary small-vessel disease affecting the brain, but these variations appear harmless in other mammals. The NOTCH3 protein has high homology among mammals, and structural or functional information from these species may aid research on NOTCH3-related conditions in humans, such as CADASIL. The study combines evolutionary genomics and protein structure analysis to reveal previously hidden functional elements. These findings provide insights into how evolutionary differences can influence protein function and disease susceptibility.[12]

References

[edit]
  1. ^ a b c GRCh38: Ensembl release 89: ENSG00000074181Ensembl, May 2017
  2. ^ a b c GRCm38: Ensembl release 89: ENSMUSG00000038146Ensembl, May 2017
  3. ^ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  4. ^ "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  5. ^ Sugaya K, Fukagawa T, Matsumoto K, Mita K, Takahashi E, Ando A, Inoko H, Ikemura T (September 15, 1994). "Three genes in the human MHC class III region near the junction with the class II: gene for receptor of advanced glycosylation end products, PBX2 homeobox gene and a notch homolog, human counterpart of mouse mammary tumor gene int-3". Genomics. 23 (2): 408–19. doi:10.1006/geno.1994.1517. PMID 7835890.
  6. ^ a b "Entrez Gene: NOTCH3 Notch homolog 3 (Drosophila)".
  7. ^ Guerreiro RJ, Lohmann E, Kinsella E, Brás JM, Luu N, Gurunlian N, Dursun B, Bilgic B, Santana I, Hanagasi H, Gurvit H, Gibbs JR, Oliveira C, Emre M, Singleton A (2012). "Exome sequencing reveals an unexpected genetic cause of disease: NOTCH3 mutation in a Turkish family with Alzheimer's disease". Neurobiol. Aging. 33 (5): 1008.e17–23. doi:10.1016/j.neurobiolaging.2011.10.009. PMC 3306507. PMID 22153900.
  8. ^ Rusanescu G, Mao J (2014). "Notch3 is necessary for neuronal differentiation and maturation in the adult spinal cord". J. Cell. Mol. Med. 18 (10): 2103–16. doi:10.1111/jcmm.12362. PMC 4244024. PMID 25164209.
  9. ^ Gripp KW, Robbins KM, Sobreira NL, Witmer PD, Bird LM, Avela K, Makitie O, Alves D, Hogue JS, Zackai EH, Doheny KF, Stabley DL, Sol-Church K (2014). "Truncating mutations in the last exon of NOTCH3 cause lateral meningocele syndrome". Am. J. Med. Genet. A. 167A (2): 271–81. doi:10.1002/ajmg.a.36863. PMC 5589071. PMID 25394726.
  10. ^ Purow B (2012). "Notch Inhibition as a Promising New Approach to Cancer Therapy". Notch Signaling in Embryology and Cancer. Advances in Experimental Medicine and Biology. Vol. 727. pp. 305–319. doi:10.1007/978-1-4614-0899-4_23. ISBN 978-1-4614-0898-7. PMC 3361718. PMID 22399357.
  11. ^ "Pfizer Oncology: ADC Development Overview (2016) » ADC Review".
  12. ^ Siddiqui KS, Ertan H, Ren Y, Poljak A, Jayasena T, Sachdev P (2025-11-02), Unveiling the evolutionary code of NOTCH3: mammalian bioinformatics sheds light on human pathogenicity, bioRxiv, doi:10.1101/2025.09.28.678708, retrieved 2025-12-05

Further reading

[edit]
[edit]